Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 13.

Corbacioglu, S; Carreras, E; Ansari, M; Balduzzi, A; Cesaro, S; Dalle, J-H; Dignan, F; Gibson, B; Güngör, Tayfun; Gruhn, B; Lankester, A; Locatelli, F; Pagliuca, A; Peters, C; Richardson, P G; Schulz, A S; Sedlacek, P; Stein, J; Sykora, K-W; Toporski, J; Trigoso, E; Vetteranta, K; Wachowiak, J; Wallhult, E; Wynn, R; Yaniv, I; Yesilipek, A; Mohty, M; Bader, P (2018). Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplantation, 53(2):138-145.

Auerbach, M; Adamson, J; Bircher, A; Breymann, C; Fishbane, S; Gafter-Gvili, A; Gasche, C; Gilreath, J; Grazzini, G; Henry, D; Liumbruno, G; Locatelli, F; Macdougall, I; Munoz, M; Rampton, D; Rodgers, G; Shander, A (2015). On the safety of intravenous iron, evidence trumps conjecture. Haematologica, 100(5):e214-e215.

Aalbers, A M; van der Velden, V H J; Yoshimi, A; Fischer, A; Noellke, P; Zwaan, C M; Baumann, I; Beverloo, H B; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Göhring, G; Schmugge, M; Stary, J; Zecca, M; Langerak, A W; van Dongen, J J M; Pieters, R; Niemeyer, C M; van den Heuvel-Eibrink, M M (2014). The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. Leukemia, 28(1):189-92.

Aalbers, A M; van den Heuvel-Eibrink, M M; Baumann, I; Beverloo, H B; Driessen, G J; Dworzak, M; Fischer, A; Göhring, G; Hasle, H; Locatelli, F; De Moerloose, B; Noellke, P; Schmugge, M; Stary, J; Yoshimi, A; Zecca, M; Zwaan, C M; van Dongen, J J M; Pieters, R; Niemeyer, C M; van der Velden, V H J; Langerak, A W (2014). T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS. Blood Cancer Journal, 4:e209.

Aalbers, A M; van den Heuvel-Eibrink, M M; de Haas, V; Te Marvelde, J G; de Jong, A X; van der Burg, M; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Schmugge, M; Stary, J; Zecca, M; Zwaan, C M; van de Loosdrecht, A A; van Dongen, J J M; Niemeyer, C M; van der Velden, V H J (2013). Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia, 27(9):1923-1925.

Olk-Batz, C; Poetsch, A R; Nöllke, P; Claus, R; Zucknick, M; Sandrock, I; Witte, T; Strahm, B; Hasle, H; Zecca, M; Stary, J; Bergstraesser, E; De Moerloose, B; Trebo, M; van den Heuvel-Eibrink, M M; Wojcik, D; Locatelli, F; Plass, C; Niemeyer, C M; Flotho, C (2011). Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood, 117(18):4871-4880.

Strahm, B; Nöllke, P; Zecca, M; Korthof, E T; Bierings, M; Furlan, I; Sedlacek, P; Chybicka, A; Schmugge, M; Bordon, V; Peters, C; O'Marcaigh, A; de Heredia, C D; Bergstraesser, E; Moerloose, B D; van den Heuvel-Eibrink, M M; Starý, J; Trebo, M; Wojcik, D; Niemeyer, C M; Locatelli, F (2011). Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia, 25(3):455-462.

Schrappe, M; Valsecchi, M G; Bartram, C R; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Parasole, R; Zimmermann, M; Dworzak, M; Buldini, B; Reiter, A; Basso, G; Klingebiel, T; Messina, C; Ratei, R; Cazzaniga, G; Koehler, R; Locatelli, F; Schäfer, B W; Aricò, M; Welte, K; van Dongen, J J M; Gadner, H; Biondi, A; Conter, V (2011). Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118(8):2077-2084.

Niemeyer, C M; Kang, M W; Shin, D H; Furlan, I; Erlacher, M; Bunin, N J; Bunda, S; Finklestein, J Z; Sakamoto, K M; Gorr, T A; Mehta, P; Schmid, I; Kropshofer, G; Corbacioglu, S; Lang, P J; Klein, C; Schlegel, P-G; Heinzmann, A; Schneider, M; Starý, J; van den Heuvel-Eibrink, M M; Hasle, H; Locatelli, F; Sakai, D; Archambeault, S; Chen, L; Russell, R C; Sybingco, S S; Ohh, M; Braun, B S; Flotho, C; Loh, M L (2010). Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nature Genetics, 42(9):794-800.

Conter, V; Bartram, C R; Valsecchi, M G; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Aricò, M; Zimmermann, M; Mann, G; De Rossi, G; Stanulla, M; Locatelli, F; Basso, G; Niggli, F; Barisone, E; Henze, G; Ludwig, W D; Haas, O A; Cazzaniga, G; Koehler, R; Silvestri, D; Bradtke, J; Parasole, R; Beier, R; van Dongen, J J M; Biondi, A; Schrappe, M (2010). Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115(16):3206-14.

Loh, M L; Sakai, D S; Flotho, C; Kang, M; Fliegauf, M; Archambeault, S; Mullighan, C G; Chen, L; Bergstraesser, E; Bueso-Ramos, C E; Emanuel, P D; Hasle, H; Issa, J P; van den Heuvel-Eibrink, M M; Locatelli, F; Stary, J; Trebo, M; Wlodarski, M; Zecca, M; Shannon, K M; Niemeyer, C M (2009). Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood, 114(9):1859-1863.

Cannata-Andía, J B; Fernández-Martín, J L; Zoccali, C; London, G M; Locatelli, F; Ketteler, M; Ferreira, A; Covic, A; Floege, J; Górriz, J L; Rutkowski, B; Memmos, D E; Verbeelen, D; Tielemans, C; Teplan, V; Bos, W J; Nagy, J; Kramar, R; Goldsmith, D J; Martin, P Y; Wüthrich, R P; Pavlovic, D; Benedik, M (2008). Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). Journal of Nephrology, 21(3):290-298.

Flotho, C; Kratz, C P; Bergsträsser, E; Hasle, H; Starý, J; Trebo, M; van den Heuvel-Eibrink, M M; Wójcik, D; Zecca, M; Locatelli, F; Niemeyer, C M (2008). Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. Blood, 111(2):966-7; author reply 967.

This list was generated on Mon Jul 23 06:46:42 2018 CEST.